Ahn CH - Search Results

1

Fluorocyclopentenyl-cytosine with broad spectrum and potent antitumor activity.

Choi WJ, Chung HJ, Chandra G, Alexander V, Zhao LX, Lee HW, Nayak A, Majik MS, Kim HO, Kim JH, Lee YB, Ahn CH, Lee SK, Jeong LS. Choi WJ, et al. Among authors: ahn ch. J Med Chem. 2012 May 10;55(9):4521-5. doi: 10.1021/jm3004009. Epub 2012 May 1. J Med Chem. 2012. PMID: 22524616

2

Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents.

Yang SH, Van HT, Le TN, Khadka DB, Cho SH, Lee KT, Chung HJ, Lee SK, Ahn CH, Lee YB, Cho WJ. Yang SH, et al. Among authors: ahn ch. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5277-81. doi: 10.1016/j.bmcl.2010.06.132. Epub 2010 Jul 3. Bioorg Med Chem Lett. 2010. PMID: 20667733

3

Design, synthesis, and anticancer activity of fluorocyclopentenyl-pyrimidines.

Zhao LX, Yun M, Kim HO, Lee JA, Choi WJ, Lee KM, Lee SK, Lee YB, Ahn CH, Jeong LS. Zhao LX, et al. Among authors: ahn ch. Nucleic Acids Symp Ser (Oxf). 2005;(49):107-8. doi: 10.1093/nass/49.1.107. Nucleic Acids Symp Ser (Oxf). 2005. PMID: 17150656

4

Synthesis and antitumor activity of fluorocyclopentenyl-pyrimidines.

Jeong LS, Zhao LX, Choi WJ, Pal S, Park YH, Lee SK, Chun MW, Lee YB, Ahn CH, Moon HR. Jeong LS, et al. Among authors: ahn ch. Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):713-6. doi: 10.1080/15257770701490852. Nucleosides Nucleotides Nucleic Acids. 2007. PMID: 18066886

5

Development of 3-aryl-1-isoquinolinamines as potent antitumor agents based on CoMFA.

Yang SH, Van HT, Le TN, Khadka DB, Cho SH, Lee KT, Lee ES, Lee YB, Ahn CH, Cho WJ. Yang SH, et al. Among authors: ahn ch. Eur J Med Chem. 2010 Nov;45(11):5493-7. doi: 10.1016/j.ejmech.2010.08.042. Epub 2010 Aug 24. Eur J Med Chem. 2010. PMID: 20817330

6

Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.

Lee YB, Gong YD, Kim DJ, Ahn CH, Kong JY, Kang NS. Lee YB, et al. Among authors: ahn ch. Bioorg Med Chem. 2012 Feb 1;20(3):1303-9. doi: 10.1016/j.bmc.2011.12.026. Epub 2011 Dec 27. Bioorg Med Chem. 2012. PMID: 22226981

7

Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.

Lee YB, Gong YD, Yoon H, Ahn CH, Jeon MK, Kong JY. Lee YB, et al. Among authors: ahn ch. Bioorg Med Chem. 2010 Nov 15;18(22):7966-74. doi: 10.1016/j.bmc.2010.09.028. Epub 2010 Sep 19. Bioorg Med Chem. 2010. PMID: 20943401

8

Antitumor activity of a novel antisense oligonucleotide against Akt1.

Yoon H, Kim DJ, Ahn EH, Gellert GC, Shay JW, Ahn CH, Lee YB. Yoon H, et al. Among authors: ahn ch, ahn eh. J Cell Biochem. 2009 Nov 1;108(4):832-8. doi: 10.1002/jcb.22311. J Cell Biochem. 2009. PMID: 19693774 Free PMC article.

9

Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).

Peters GJ, Smid K, Vecchi L, Kathmann I, Sarkisjan D, Honeywell RJ, Losekoot N, Ohne O, Orbach A, Blaugrund E, Jeong LS, Lee YB, Ahn CH, Kim DJ. Peters GJ, et al. Among authors: ahn ch. Invest New Drugs. 2013 Dec;31(6):1444-57. doi: 10.1007/s10637-013-0025-x. Epub 2013 Sep 19. Invest New Drugs. 2013. PMID: 24048768

10

Lipid-Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α.

Li H, Quan J, Zhang M, Yung BC, Cheng X, Liu Y, Lee YB, Ahn CH, Kim DJ, Lee RJ. Li H, et al. Among authors: ahn ch. Mol Pharm. 2016 Jul 5;13(7):2555-62. doi: 10.1021/acs.molpharmaceut.6b00363. Epub 2016 Jun 16. Mol Pharm. 2016. PMID: 27253378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

473 results

Search Page